Corroborating its oncogenic potential, CCND1 mutations affecting Thr286 phosphorylation and inhibiting nuclear export have been reported in a few cancers [10][12][11]; however, the frequency and spectrum of CCND1 mutations have not been systematically investigated or reported across a large series of cases and across a variety of cancer subtypes. Here, CCND1 is linked to cancer.